The 2023 British Thoracic Society Guideline for Pleural Disease Update on Malignant Pleural Effusion

Thumbnail Image
Files
The 2023 British Thoracic Society Guideline for Pleural Disease.pdf (451.8 KB)
Authors
Aujayeb, Avinash
Issue Date
2024
Type
Article
Language
en
Keywords
pleural effusion , diagnostics , talc pleurodesis , chest drain
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
The management of malignant pleural effusions (MPEs) has developed hugely since the publication of the management of an MPE: British Thoracic Society (BTS) Pleural Disease Guideline 2010. The presence of an MPE reflects advanced or metastatic disease (excluding malignant pleural mesothelioma) and thus the management of MPE often focuses on symptomatic relief of symptoms and improving quality of life. We provide a review of the 2023 BTS guidance in relation to malignant pleural effusions and specific points on imaging and systemic anti-cancer treatment by concentrating on a hypothetical patient vignette.
Description
Citation
Kavita Sivabalah et al. (2024) ‘The 2023 British Thoracic Society Guideline for Pleural Disease Update on Malignant Pleural Effusion’, Journal of Respiration, 4(4), pp. 210–222. doi:10.3390/jor4040019.
Publisher
License
Journal
Journal of Respiration
Volume
Issue
URI
https://hdl.handle.net/20.500.14445/1339
PubMed ID
DOI
https://doi.org/10.3390/jor4040019
ISSN
2673-527X
EISSN
Collections
Respiratory